Your browser doesn't support javascript.
COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher's Stone?
Penlioglou, Theano; Papachristou, Stella; Papanas, Nikolaos.
  • Penlioglou T; Second Department of Internal Medicine, Diabetes Centre, Democritus University of Thrace, Alexandroupolis, Greece.
  • Papachristou S; Second Department of Internal Medicine, Diabetes Centre, Democritus University of Thrace, Alexandroupolis, Greece.
  • Papanas N; Second Department of Internal Medicine, Diabetes Centre, Democritus University of Thrace, Alexandroupolis, Greece.
Diabetes Ther ; 11(6): 1195-1197, 2020 Jun.
Article in English | MEDLINE | ID: covidwho-197872
ABSTRACT
Corona virus infectious disease (COVID-19) is a new pandemic. In subjects with diabetes mellitus, infection may be more frequent and severe. We discuss the potential contribution of two traditional oral antidiabetic agents, metformin and pioglitazone, to the improvement of liver injury in COVID-19. Clearly, further experience is needed to shed light on these hypotheses.
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Diabetes Ther Year: 2020 Document Type: Article Affiliation country: S13300-020-00830-0

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Diabetes Ther Year: 2020 Document Type: Article Affiliation country: S13300-020-00830-0